DuChemBIO Co.,Ltd. (KOSDAQ:176750)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,920.00
+220.00 (2.27%)
At close: Oct 2, 2025

DuChemBIO Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
Operating Revenue
35,81535,60134,695
Other Revenue
---0
35,81535,60134,695
Revenue Growth (YoY)
-2.61%-
Cost of Revenue
23,69023,36722,898
Gross Profit
12,12512,23411,797
Selling, General & Admin
5,7195,5485,087
Research & Development
--205.31
Operating Expenses
7,1377,1586,541
Operating Income
4,9885,0765,256
Interest Expense
-940.76-1,091-1,364
Interest & Investment Income
139.4889.6490.89
Earnings From Equity Investments
621.61,106-69.64
Currency Exchange Gain (Loss)
-9.11-34.84-7.99
Other Non Operating Income (Expenses)
-39.0230.2368.38
EBT Excluding Unusual Items
4,7605,1773,974
Gain (Loss) on Sale of Investments
387.82387.8292.13
Gain (Loss) on Sale of Assets
-0.18-0.1816.28
Asset Writedown
---30.7
Pretax Income
5,1485,5644,052
Income Tax Expense
-2,111-2,42951.23
Net Income
7,2597,9944,001
Net Income to Common
7,2597,9944,001
Net Income Growth
-99.82%-
Shares Outstanding (Basic)
282727
Shares Outstanding (Diluted)
282727
Shares Change (YoY)
-0.43%-
EPS (Basic)
262.40297.54149.54
EPS (Diluted)
262.40297.54149.54
EPS Growth
-98.97%-
Free Cash Flow
6,5655,4407,293
Free Cash Flow Per Share
237.31202.48272.63
Gross Margin
33.85%34.36%34.00%
Operating Margin
13.93%14.26%15.15%
Profit Margin
20.27%22.45%11.53%
Free Cash Flow Margin
18.33%15.28%21.02%
EBITDA
10,72010,64111,016
EBITDA Margin
29.93%29.89%31.75%
D&A For EBITDA
5,7325,5655,760
EBIT
4,9885,0765,256
EBIT Margin
13.93%14.26%15.15%
Effective Tax Rate
--1.26%
Advertising Expenses
-76.1862.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.